The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 06, 2026
Snapshot (as of Jul 06, 2026): Roche Holding AG (RHHBY) pays a $9.80 annual dividend ($0.82 monthly), yielding 2.89% at $53.04/share. Next ex-dividend date 2026-03-13. 8 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.89%
Annual Dividend: $9.80 per share
Payout Ratio: 35.1%
Ex-Dividend Date: 2026-03-13
Dividend Frequency: monthly
Sector: Healthcare
Years of Dividend History: 34
Roche Holding AG dividend investors are looking at a global healthcare company founded in 1896, with operations spanning oncology, neuroscience, and diagnostics across more than eight countries. The current yield stands at 2.92%, with a trailing annual dividend rate of $9.80 per share paid monthly. The next ex-dividend date is March 13, 2026, and the last dividend amount was $1.5495 per share. With a beta of 0.326, RHHBY stock moves far less than the broader market, which suits income investors who prioritize low volatility over aggressive growth.
Roche Holding AG pays out 35.1% of earnings as dividends, a payout ratio classified as conservative (below 40%). That level of earnings retention gives the company room to fund its pharmaceutical and diagnostics pipeline, which spans treatments for cancer, hemophilia, and autoimmune disorders alongside laboratory testing products. Roche Holding AG dividend safety benefits from this low payout floor, though the dividend history does contain at least one year-over-year decline exceeding 5%, which means past payments have not been immune to pressure.
Roche Holding AG dividend history shows a CAGR of -2.8% per year from 2008 to 2025. Per-share payments moved from $2.2519 at the start of the window to $1.3890 by 2025 (2026 is a partial year and excluded from this calculation). The window also contains at least one year-over-year decline exceeding 5%, so growth has not been linear. On the positive side, RHHBY has posted 8 consecutive years of dividend increases, and the largest single-year jump in the data was 27.1% in 2011.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.8% | $1.24 (2022) | $1.39 (2025) |
| 5-Year | +4.1% | $1.14 (2020) | $1.39 (2025) |
| 10-Year | +3.3% | $1.00 (2015) | $1.39 (2025) |
RHHBY fits dividend investors who want moderate, low-volatility income from a global healthcare business rather than rapid payout growth. The current yield of 2.92% sits above the 5-year average of 2.5%, which means the stock is currently offering more income than its recent norm. That yield falls in the moderate (2-4%) range, backed by a conservative 35.1% payout ratio. The trade-off is clear: the long-term CAGR of -2.8% per year means the dividend has shrunk in real terms over the full history window, even as the 8-year consecutive increase streak points to a more recent shift toward growth. Roche Holding AG stock offers income with low market sensitivity, but purchasing power from the dividend alone has eroded over time.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-13 | $1.5495 |
| 2025-03-28 | $1.3890 |
| 2024-03-14 | $1.3494 |
| 2023-03-16 | $1.2794 |
| 2022-03-17 | $1.2407 |
| 2021-03-18 | $1.2206 |
| 2020-03-19 | $1.1366 |
| 2019-03-07 | $1.0746 |
| 2018-03-15 | $0.8918 |
| 2017-03-15 | $0.8458 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.5495 |
| 2025 | $1.3890 |
| 2024 | $1.3494 |
| 2023 | $1.2794 |
| 2022 | $1.2407 |
Project income from RHHBY with the RHHBY dividend calculator or track your full portfolio with the dividend tracker.